Exclusive Summary

• Essential Medicine with High Clinical Value: As a WHO Essential Medicine and guideline-recommended first-line treatment, Aripiprazole 10mg is favored globally for its superior metabolic safety profile, serving as the gold standard for maintenance therapy.
• Massive Chronic Patient Pool: Targeting over 24 million schizophrenia and 40 million bipolar patients worldwide, the lifelong nature of these psychiatric diseases guarantees consistent, high-volume recurring orders for distributors.
• Superior Cost Competitiveness: With originator patents long expired, leveraging China's highly scalable manufacturing capacity provides overseas partners with aggressive pricing to easily win national tenders and hospital procurements.
• Complete Regulatory & Compliance Support: Backed by international-standard CTD dossiers and rigorous GMP compliance, enabling distributors to achieve fast-track registration and seamless localization in diverse global markets.